ATLANTA -- Teen and childhood suicides rose sharply in 2004, for the first time in more than 10 years, and some are linking this to a reduced use of antidepressants that year because of black box label warnings mandated by the FDA.
ATLANTA, Feb. 6 -- Teen and childhood suicides rose sharply in 2004, for the first time in more than 10 years, and some are linking this to a reduced use of antidepressants that year because of black box label warnings mandated by the FDA.
According to figures compiled by the CDC there were 1,985 suicides among those ages 10 through 19 in 2004, compared with 1,737 in 2003.
That's a rate of 2.6 per 100,000, up from 2.2 per 100,000 the year before, according to the Annual Summary of Vital Statistics, published in the February issue of Pediatrics.
Overall, the death rate from suicide increased by 18.2% -- a change that was deemed "unacceptable" by David Shern, Ph.D., president of Mental Health America.
Dr. Shern said it's premature to draw conclusions about the cause of the increase, but noted that it coincided with the FDA's warning that selective serotonin reuptake inhibitors (SSRIs) had been linked to suicidal thoughts in young people.
The warnings created a barrier to treatment "by scaring young people and parents away from care" that may be linked to the rise in suicide, Dr. Shern said in a statement.
Charles Nemeroff, M.D., Ph.D., of Emory University School of Medicine here told reporters he has no doubt that the warning contributed to the suicide increase.
"The concerns about antidepressant use in children and adolescents have paradoxically resulted in a reduction in their use, and this has contributed to increased suicide rates," Dr. Nemeroff said.
Noting that the adolescent suicide rate had been falling, David Fassler, M.D., of the University of Vermont in Burlington, Vt., called the new data "very disturbing."
"The sudden increase in the adolescent suicide rate," Dr. Fassler told reporters, "corresponds to the significant and precipitous decrease in the use of SSRI antidepressants in this age group."
He said there are no data showing that SSRIs increase the risk of suicide and "the current data suggest that the decreased use of these medications is, in fact, associated with an increase in actual deaths attributable to suicide."
But the warnings may not be the only reason for the spike, according to Bernadette Melnyk, Ph.D., R.N., of Arizona State University in Phoenix. She told reporters the U.S. is short about 30,000 child psychiatrists "so the gaps in mental health services for those children and youth who need them are huge."
She said that one in four teens has a mental health problem and only about a quarter of them are treated.
Aside from the teen suicide numbers, the survey presented a statistical grab-bag, including:
The statistical survey noted that most of the causes of death among youngsters remained unchanged, with the exceptions of suicide and of influenza and pneumonia, which fell by 40%.
Overall, 25,325 children and adolescents died in 2004, 44% of them from unintentional injuries, according to Brady Hamilton, Ph.D., of the CDC.
The death rate for youngsters was 32.7 per 100,000 populations, slightly lower (0.9%) compared with the 33.0 in 2003.
Over all age groups, the death rate was 816.5 per 100 000 population, a 3.0% decrease from the final 2003 rate of 841.9. All told, 2,397,615 Americans died in 2004.
As for births, the survey found, the excess of birth over deaths in 2004, was slightly more than 1.7 million, while the preliminary data for 2005 show 4,140,419 births, an increase of about 1%.
The survey also found: